HTEC Robo Global® Hlthcare Tech & Innovt ETF
ROBO Gbl Healthcare Tech & Innov PR USD

NAV as of 16-May-2022

28.9900

4 Week: 27.22 - 34.92

52 Week: 27.22 - 50.19

Latest Closing Price

29.79

Premium / Discount

-0.36

Expense Ratio

0.68%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Main Fund Characteristics

Fund Manager:
Robo Global
Asset Under Management:
116,696,898
Launch Date:
23/06/2019
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
85
Trading Currency:
USD
Style:
Mid Growth
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-34.002.37-14.34
1 Day-3.460.000.00
1 Week5.667.760.73
1 Month-15.7113.73-1.14
3 Months-18.0920.08-0.90
6 Months-36.3724.58-1.48
1 Year-33.5227.21-1.23
2 Years-1.6436.53-0.04
3 Years0.000.000.00
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.000065.2174-0.1456
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00003.000075.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 85

Number of Bond Holdings: 0

Number of Equity Holdings: 85

Total Market Value: 116,696,898

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Teladoc Health Inc1.8463846067,976
2Myriad Genetics Inc1.74081,826064,093
3Natera Inc1.71481,645063,135
4Align Technology Inc1.7079243062,881
5Penumbra Inc1.6740384061,632
6Abiomed Inc1.6643278061,277
7Arrowhead Pharmaceuticals Inc1.64841,538060,689
8Siemens Healthineers AG Registered Shares1.62121,274059,691
9Staar Surgical Co1.60571,693059,120
10Illumina Inc1.6001194058,914

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant6.77
Large24.20
Medium29.11
Small22.58
Micro17.39

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

22.6222

Price/Book*

2.4406

Price/Sales*

2.8992

Price/Cash Flow*

10.4124

Dividend Yield*

0.4251

Growth Measures

Long-Term Earnings

12.7346

Historical Earnings

25.7336

Sales Growth

15.1003

Cash-Flow Growth

62.9204

Book-Value Growth

26.6488

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.